GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Solarvest BioEnergy Inc (TSXV:SVS.H) » Definitions » Debt-to-Asset

Solarvest BioEnergy (TSXV:SVS.H) Debt-to-Asset : 4.33 (As of Jan. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Solarvest BioEnergy Debt-to-Asset?

Solarvest BioEnergy's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$2.90 Mil. Solarvest BioEnergy's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$0.02 Mil. Solarvest BioEnergy's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jan. 2024 was C$0.67 Mil. Solarvest BioEnergy's debt to asset for the quarter that ended in Jan. 2024 was 4.33.


Solarvest BioEnergy Debt-to-Asset Historical Data

The historical data trend for Solarvest BioEnergy's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solarvest BioEnergy Debt-to-Asset Chart

Solarvest BioEnergy Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 1.08 1.38 2.56 4.39

Solarvest BioEnergy Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.18 2.47 4.39 4.72 4.33

Competitive Comparison of Solarvest BioEnergy's Debt-to-Asset

For the Biotechnology subindustry, Solarvest BioEnergy's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solarvest BioEnergy's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Solarvest BioEnergy's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Solarvest BioEnergy's Debt-to-Asset falls into.



Solarvest BioEnergy Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Solarvest BioEnergy's Debt-to-Asset for the fiscal year that ended in Jul. 2023 is calculated as

Solarvest BioEnergy's Debt-to-Asset for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solarvest BioEnergy  (TSXV:SVS.H) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Solarvest BioEnergy Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Solarvest BioEnergy's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Solarvest BioEnergy (TSXV:SVS.H) Business Description

Traded in Other Exchanges
N/A
Address
301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2
Solarvest BioEnergy Inc is a Canada based algae biologics company whose production platform provides flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has also initiated a program for the expression of CBD and THC to be produced.

Solarvest BioEnergy (TSXV:SVS.H) Headlines

No Headlines